Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Sedation in Cardiac Arrest
NCT04360070Unknown
- Sponsor
- Fraser Health
- Start
- Feb 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ketamine in cardiac arrest (SCA) (2 arms), sponsored by Fraser Health. Primary endpoint: Feasibility Data at 6 months. Status: unknown.
02
Drugs
ketamine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT04360070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04360070.